PRFX
PRF Technologies Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$0.75
+4.81%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 0.04x
- P/S forward
- 119.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.16x
- Price / sales
- 66.01x
- Price / cash flow
- -0.35x
Enterprise value
- Enterprise value
- -$8.3M
- EV / sales
- -209.50x
- EV / EBITDA
- 1.12x
- EV / EBIT
- 0.92x
- Market cap
- $2.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026